Barpisoflavone ACAS# 101691-27-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 101691-27-4 | SDF | Download SDF |
PubChem ID | 9944143 | Appearance | Yellow powder |
Formula | C16H12O6 | M.Wt | 300.27 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxychromen-4-one | ||
SMILES | COC1=C2C(=CC(=C1)O)OC=C(C2=O)C3=C(C=C(C=C3)O)O | ||
Standard InChIKey | TUTSVLUUGMNALO-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Barpisoflavone A possesses moderate estrogen partial agonistic activities and moderate antioxidant activities. |
Targets | Estrogen receptor | Progestogen receptor |
Barpisoflavone A Dilution Calculator
Barpisoflavone A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3303 mL | 16.6517 mL | 33.3034 mL | 66.6067 mL | 83.2584 mL |
5 mM | 0.6661 mL | 3.3303 mL | 6.6607 mL | 13.3213 mL | 16.6517 mL |
10 mM | 0.333 mL | 1.6652 mL | 3.3303 mL | 6.6607 mL | 8.3258 mL |
50 mM | 0.0666 mL | 0.333 mL | 0.6661 mL | 1.3321 mL | 1.6652 mL |
100 mM | 0.0333 mL | 0.1665 mL | 0.333 mL | 0.6661 mL | 0.8326 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Cyclo(Phe-Hpro)
Catalog No.:BCN2425
CAS No.:1016899-94-7
- Cyclo(Hpro-Leu)
Catalog No.:BCN2430
CAS No.:1016899-93-6
- Drevogenin A
Catalog No.:BCN4740
CAS No.:10163-83-4
- Sodium Monofluorophosphate
Catalog No.:BCC4722
CAS No.:10163-15-2
- Diacetylpiquerol A
Catalog No.:BCC8935
CAS No.:130466-34-1
- Kadsuracoccinic acid A
Catalog No.:BCN5829
CAS No.:1016260-22-2
- Talipexole
Catalog No.:BCC5250
CAS No.:101626-70-4
- Trenbolone acetate
Catalog No.:BCC9184
CAS No.:10161-34-9
- Trenbolone
Catalog No.:BCC9183
CAS No.:10161-33-8
- N-Acetyltryptamine
Catalog No.:BCC6618
CAS No.:1016-47-3
- 6-O-Nicotinoylbarbatin C
Catalog No.:BCN5828
CAS No.:1015776-92-7
- GSK 4716
Catalog No.:BCC7557
CAS No.:101574-65-6
- Olivil monoacetate
Catalog No.:BCN4738
CAS No.:1016974-78-9
- Sulfocostunolide A
Catalog No.:BCN5830
CAS No.:1016983-51-9
- 6-O-p-Hydroxybenzoylaucubin
Catalog No.:BCN5831
CAS No.:1016987-87-3
- Myzodendrone
Catalog No.:BCN7257
CAS No.:101705-37-7
- (S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone
Catalog No.:BCC8399
CAS No.:101711-78-8
- 6alpha,16,18-Trihydroxycleroda-3,13-dien-15,16-olide
Catalog No.:BCN1640
CAS No.:1017233-48-5
- Sanggenofuran B
Catalog No.:BCN7194
CAS No.:1017277-40-5
- Jaceidin
Catalog No.:BCN5832
CAS No.:10173-01-0
- Nevadensin
Catalog No.:BCN6806
CAS No.:10176-66-6
- Ladanein
Catalog No.:BCN6670
CAS No.:10176-71-3
- LPA2 antagonist 1
Catalog No.:BCC5438
CAS No.:1017606-66-4
- PK 44 phosphate
Catalog No.:BCC2366
CAS No.:1017682-65-3
Biological activities of unique isoflavones prepared from Apios americana Medik.[Pubmed:26806328]
Biosci Biotechnol Biochem. 2016;80(4):774-8.
Four unique isoflavone aglycones (Barpisoflavone A (1), 2'-hydroxygenistein (2), 5-methylgenistein (3), and gerontoisoflavone A (4)) whose structures were related to genistein were prepared from the tuber of Apios americana Medik. We examined the estrogen receptor and androgen receptor binding activities, estrogen agonistic activities, antioxidant activities, and alpha-glucosidase inhibitory activities of 1-4. The results obtained showed that 2 possessed potent and 1, 3, and 4 possessed moderate estrogen partial agonistic activities, 1 and 2 possessed moderate antioxidant activities, and 2 and 3 possessed moderate alpha-glucosidase inhibitory activities.